Zobrazeno 1 - 10
of 10
pro vyhledávání: '"van Lawick van Pabst AE"'
Autor:
Verster, JC, Kruisselbrink, LD, Slot, KA, Anogeianaki, A, Adams, S, Alford, C, Arnoldy, L, Ayre, E, Balikji, S, Benson, S, Bruce, G, Devenney, LE, Frone, MR, Gunn, C, Heffernan, T, Hensel, KO, Hogewoning, A, Johnson, SJ, van Lawick van Pabst, AE, van de Loo, AJAE, Mackus, M, Merlo, A, Murphy, RJL, Owen, LJ, Palmer, EOC, van Rossum, CJI, Scholey, A, Terpstra, C, Vatsalya, V, Vermeulen, SA, van Wijk, M, Stock, AK
Publikováno v:
Journal of Clinical Medicine, Vol 9, Iss 1, p 179 (2020)
Journal of Clinical Medicine
Journal of Clinical Medicine
The 2010 Alcohol Hangover Research Group consensus paper defined a cutoff blood alcohol concentration (BAC) of 0.11% as a toxicological threshold indicating that sufficient alcohol had been consumed to develop a hangover. The cutoff was based on prev
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::f57c5003b9c62ff49d933e28cf1294c4
https://usir.salford.ac.uk/id/eprint/56189/1/jcm-09-00179.pdf
https://usir.salford.ac.uk/id/eprint/56189/1/jcm-09-00179.pdf
Autor:
Verster JC; Division of Pharmacology, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, 3584CG Utrecht, The Netherlands.; Institute for Risk Assessment Sciences (IRAS), Utrecht University, 3584CM Utrecht, The Netherlands.; Centre for Human Psychopharmacology, Swinburne University, Melbourne, VIC 3122, Australia., Kruisselbrink LD; Centre of Lifestyle Studies, School of Kinesiology, Acadia University, Wolfville, NS B4P 2R6, Canada., Slot KA; Division of Pharmacology, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, 3584CG Utrecht, The Netherlands., Anogeianaki A; Division of Pharmacology, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, 3584CG Utrecht, The Netherlands., Adams S; Addiction and Mental Health Group, Department of Psychology, University of Bath, Bath BA2 7AY, UK., Alford C; Psychological Sciences Research Group, University of the West of England, Bristol BS16 1QY, UK., Arnoldy L; Division of Pharmacology, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, 3584CG Utrecht, The Netherlands., Ayre E; Centre for Human Psychopharmacology, Swinburne University, Melbourne, VIC 3122, Australia., Balikji S; Division of Pharmacology, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, 3584CG Utrecht, The Netherlands., Benson S; Centre for Human Psychopharmacology, Swinburne University, Melbourne, VIC 3122, Australia., Bruce G; Education and Social Sciences, University of the West of Scotland, Paisley PA1 2BE, UK., Devenney LE; School of Psychology, Life and Health Sciences, Ulster University, Coleraine, Co. Londonderry BT52 1SA, UK., Frone MR; Department of Psychology, University at Buffalo, The State University of New York, Buffalo, NY 14203, USA., Gunn C; Addiction and Mental Health Group, Department of Psychology, University of Bath, Bath BA2 7AY, UK., Heffernan T; Department of Psychology, Faculty of Health and Life Sciences, Northumbria University, Newcastle upon Tyne NE1 8ST, UK., Hensel KO; Cambridge Biomedical Campus, Department of Paediatrics, Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 0QQ, UK.; Faculty of Health, Department of Paediatrics, Center for Clinical & Translational Research (CCTR), Witten/Herdecke University, 58455 Witten, Germany., Hogewoning A; Division of Pharmacology, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, 3584CG Utrecht, The Netherlands., Johnson SJ; Psychological Sciences Research Group, University of the West of England, Bristol BS16 1QY, UK.; Centre for Trials Research, Cardiff University, Cardiff CF14 4YS, UK., van Lawick van Pabst AE; Division of Pharmacology, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, 3584CG Utrecht, The Netherlands., van de Loo AJAE; Division of Pharmacology, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, 3584CG Utrecht, The Netherlands., Mackus M; Division of Pharmacology, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, 3584CG Utrecht, The Netherlands., Merlo A; Education and Social Sciences, University of the West of Scotland, Paisley PA1 2BE, UK., Murphy RJL; Centre of Lifestyle Studies, School of Kinesiology, Acadia University, Wolfville, NS B4P 2R6, Canada., Owen L; Department of Psychology, School of Health and Society, University of Salford, Salford 5 M6 6PU, UK., Palmer EOC; Department of Medicine, Imperial College London, London W12 0NN, UK., van Rossum CJI; Division of Pharmacology, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, 3584CG Utrecht, The Netherlands., Scholey A; Centre for Human Psychopharmacology, Swinburne University, Melbourne, VIC 3122, Australia., Terpstra C; Centre for Human Psychopharmacology, Swinburne University, Melbourne, VIC 3122, Australia., Vatsalya V; Department of Medicine, University of Louisville, Louisville, KY 40202, USA.; Alcohol Research Center, University of Louisville, Louisville, KY 40202, USA.; Hepatobiology & Toxicology Center, University of Louisville, Louisville, KY 40202, USA.; National Institute on Alcohol Abuse and Alcoholism, NIH, Bethesda, MD 20892, USA.; Robley Rex Louisville VAMC, Louisville, KY 40206, USA., Vermeulen SA; Division of Pharmacology, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, 3584CG Utrecht, The Netherlands., van Wijk M; Division of Pharmacology, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, 3584CG Utrecht, The Netherlands., Stock AK; Cognitive Neurophysiology Department of Child and Adolescent Psychiatry, Faculty of Medicine of the TU Dresden, University of Dresden, D-01307 Dresden, Germany.
Publikováno v:
Journal of clinical medicine [J Clin Med] 2020 Jan 09; Vol. 9 (1). Date of Electronic Publication: 2020 Jan 09.
Autor:
Verster JC; Division of Pharmacology, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, 3584CG Utrecht, The Netherlands. j.c.verster@uu.nl.; Institute for Risk Assessment Sciences (IRAS), Utrecht University, 3584CM Utrecht, The Netherlands. j.c.verster@uu.nl.; Centre for Human Psychopharmacology, Swinburne University, VIC 3122 Melbourne, Australia. j.c.verster@uu.nl., Slot KA; Division of Pharmacology, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, 3584CG Utrecht, The Netherlands., Arnoldy L; Division of Pharmacology, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, 3584CG Utrecht, The Netherlands., van Lawick van Pabst AE; Division of Pharmacology, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, 3584CG Utrecht, The Netherlands., van de Loo AJAE; Division of Pharmacology, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, 3584CG Utrecht, The Netherlands.; Institute for Risk Assessment Sciences (IRAS), Utrecht University, 3584CM Utrecht, The Netherlands., Benson S; Centre for Human Psychopharmacology, Swinburne University, VIC 3122 Melbourne, Australia., Scholey A; Centre for Human Psychopharmacology, Swinburne University, VIC 3122 Melbourne, Australia.
Publikováno v:
Journal of clinical medicine [J Clin Med] 2019 Sep 21; Vol. 8 (10). Date of Electronic Publication: 2019 Sep 21.
Autor:
van Lawick van Pabst AE; Division of Pharmacology, Utrecht University, 3584 CG Utrecht, The Netherlands., Devenney LE; School of Psychology, Life and Health Sciences Ulster University, Londonderry BT52 1SA, Northern Ireland, UK., Verster JC; Division of Pharmacology, Utrecht University, 3584 CG Utrecht, The Netherlands. J.C.Verster@uu.nl.; Centre for Human Psychopharmacology, Swinburne University, Melbourne VIC 3122, Australia. J.C.Verster@uu.nl.
Publikováno v:
Journal of clinical medicine [J Clin Med] 2019 Aug 26; Vol. 8 (9). Date of Electronic Publication: 2019 Aug 26.
Autor:
van Lawick van Pabst AE; Division of Pharmacology, Utrecht University, 3584 CG Utrecht, The Netherlands. albertinevanlawick@live.nl., Devenney LE; School of Psychology, Life and Health sciences Ulster University, BT52 1SA Londonderry, Northern Ireland. Devenney-l2@ulster.ac.uk., Verster JC; Division of Pharmacology, Utrecht University, 3584 CG Utrecht, The Netherlands. J.C.Verster@uu.nl.; Centre for Human Psychopharmacology, Swinburne University, Melbourne, VIC 3122, Australia. J.C.Verster@uu.nl.
Publikováno v:
Journal of clinical medicine [J Clin Med] 2019 Jun 17; Vol. 8 (6). Date of Electronic Publication: 2019 Jun 17.
Autor:
Pont-Fernandez, Salma1 (AUTHOR), Kheyfets, Marina1 (AUTHOR), Rogers, Jeffrey M.1 (AUTHOR), Smith, Kirsten E.1 (AUTHOR), Epstein, David H.1 (AUTHOR) david.epstein@nih.gov
Publikováno v:
American Journal of Drug & Alcohol Abuse. 2023, Vol. 49 Issue 1, p85-96. 12p.
Autor:
Ayre, Elizabeth1 (AUTHOR), Benson, Sarah1 (AUTHOR), Garrisson, Harriet1 (AUTHOR), Cox, Katherine H. M.1 (AUTHOR), Verster, Joris C.1,2 (AUTHOR), Scholey, Andrew1,3 (AUTHOR) andrew@scholeylab.com
Publikováno v:
Psychopharmacology. Aug2022, Vol. 239 Issue 8, p2695-2704. 10p. 1 Chart, 3 Graphs.
Publikováno v:
European Addiction Research; Aug2023, Vol. 29 Issue 4, p294-304, 10p
Publikováno v:
Drug & Alcohol Review. Nov2019 Supplement S1, Vol. 38, pS110-S115. 6p.
A current survey and synthesis of the most important findings in our understanding of the neurobiological mechanisms of addiction is detailed in our Neurobiology of Addiction series, each volume addressing a specific area of addiction. Alcohol, Volum